Meningococcal serogroup B vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Meningococcal serogroup B vaccine, covering 2016-09-16 to 2016-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs [Phase 2]